INVES 21

Trend of Stock Market

A trend is the broad upward or downward movement of a stock's price over time

Forthcoming IPO Open Issues Closed Issue
Forthcoming Issues Open Issues Closed Issue
World Indices ADR Prices MF Investment FII Investment
Get Quotes Company Snapshot Company Background Board of Directors Directors Reports Profit & Loss Balance Sheet Quarterly Results Shareholding Pattern Key Financial Ratios Mutual Fund Holdings Peer Comparison Technical Chart

Profit & Loss

Change Company Name

Biocon Ltd

Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code 532523	ISIN Demat INE376G01013	Book Value 119.85	NSE Symbol BIOCON	Dividend Yield (%) 0.12	Market Cap (₹ Cr.) 51,199.02	P/E 0	EPS 0.34	Face Value 5

Particulars (₹ Cr)	Mar2025	Mar2024	Mar2023	Mar2022	Mar2021
Revenue From Operations	2,242.60	2,127.30	1,992.90	1,738.20	2,028.40
Sale of Products	1,822.40	1,712.40	1,729.40	1,494.90	1,818.80
Sale of Services	10.90	11.20	2.10	2.50	4.00
Income from Investment and Financial Services	0.00	0.00	0.00	0.00	0.00
Income from Insurance Operations	0.00	0.00	0.00	0.00	0.00
Other Operating Revenue	409.30	403.70	261.40	240.80	205.60
Less: Excise Duty / GST	0.00	0.00	0.00	0.00	0.00
Revenue From Operations - Net	2,242.60	2,127.30	1,992.90	1,738.20	2,028.40
Other Income	242.30	193.00	271.40	187.20	150.20
Total Revenue	2,484.90	2,320.30	2,264.30	1,925.40	2,178.60
Changes in Inventories	-54.60	-99.10	3.20	-105.80	36.70
Cost of Material Consumed	1,085.40	1,033.30	978.90	912.30	760.70
Internally Manufactured Intermediates Consumed	0.00	0.00	0.00	0.00	0.00
Purchases of Stock-in-Trade	0.00	0.50	2.10	1.70	0.90
Employee Benefits	501.30	452.30	433.80	367.70	390.20
Total Other Expenses	534.70	477.60	551.40	501.20	527.40
Manufacturing / Operating Expenses	355.80	370.70	406.30	361.50	333.00
Administrative and Selling Expenses	172.00	135.00	112.20	106.70	128.40
Other Expenses	6.90	-28.10	32.90	33.00	66.00
Finance Costs	236.90	198.80	69.60	0.40	0.40
Depreciation and Amortization	127.80	121.10	116.90	108.20	103.50
Total Expenses	2,431.50	2,184.50	2,155.90	1,785.70	1,819.80
Profit Before Exceptional Items and Tax	53.40	135.80	108.40	139.70	358.80
Exceptional Items Before Tax	607.50	14.50	2,862.80	0.00	0.00
Profit Before Extraordinary Items and Tax	660.90	150.30	2,971.20	139.70	358.80
Extraordinary Items Before Tax	0.00	0.00	0.00	0.00	0.00
Other Adjustments Before Tax	0.00	0.00	0.00	0.00	0.00
Profit Before Tax	660.90	150.30	2,971.20	139.70	358.80
Taxation	51.60	31.00	122.80	53.60	78.30
Current Tax	30.60	15.10	25.60	32.20	46.20
MAT Credit Entitlement	0.00	0.00	107.10	28.50	27.30
Deferred Tax	21.00	15.90	-9.90	-7.10	4.80
Other Tax	0.00	0.00	0.00	0.00	0.00
Adjust for Previous Year	0.00	0.00	0.00	0.00	0.00
Profit After Tax	609.30	119.30	2,848.40	86.10	280.50
Extraordinary Items After Tax	0.00	0.00	0.00	0.00	0.00
Discontinued Operations After Tax	0.00	0.00	0.00	0.00	0.00
Profit / (Loss) from Discontinuing Operations	0.00	0.00	0.00	0.00	0.00
Tax Expenses of Discontinuing Operations	0.00	0.00	0.00	0.00	0.00
Profit Attributable to Shareholders	609.30	119.30	2,848.40	86.10	280.50
Adjustments to Net Income	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00
Profit Attributable to Equity Shareholders	609.30	119.30	2,848.40	86.10	280.50
Earning Per Share - Basic	5.09	1.00	23.87	0.72	2.36
Earning Per Share - Diluted	5.09	1.00	23.82	0.72	2.34
Operation Profit before Depreciation	418.10	455.70	294.90	248.30	462.70
Operating Profit after Depreciation	290.30	334.60	178.00	140.10	359.20
Dividend Per Share	0.50	0.50	1.50	0.50	0.00
Dividend Percentage	10.00	10.00	30.00	10.00	0.00
Equity Dividend	60.00	60.03	180.09	60.03	0.00
Weighted Average Shares - Basic	119.75	119.54	119.31	119.11	118.71
Weighted Average Shares - Diluted	119.82	119.69	119.59	119.64	119.68